TNF-receptor levels in preeclampsia—results of a longitudinal study in high-risk women

References

• National High Blood Pressure Education Program Working Group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990; 163: 1691–1712
   PubMed Web of Science ®Google Scholar
• Brown M A, Hague W M, Higgins J, Lowe S, McCowan L, Oats J, Peek M J, Rowan J A, Walters B N. The detection, investigation and management of hypertension in pregnancy: Full consensus statement. Aust N Z J Obstet Gynaecol 2000; 40: 139–155
   PubMed Web of Science ®Google Scholar
• Brown M A, Lindheimer M D, de Swiet M, Van Assche A, Moutquin J M. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: IX–XIV
   PubMed Web of Science ®Google Scholar
• Roberts J M. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998; 16: 5–15
   PubMedGoogle Scholar
• Dekker G A, Robillard P Y, Hulsey T C. Immune maladaptation in the etiology of preeclampsia: A review of corroborative epidemiologic studies. Obstet Gynecol Surv 1998; 53: 377–382
   PubMedGoogle Scholar
• Dekker G A, Sibai B M. Etiology and pathogenesis of preeclampsia: Current concepts. Am J Obstet Gynecol 1998; 179: 1359–1375
   PubMed Web of Science ®Google Scholar
• Dekker G A, Sibai B M. The immunology of preeclampsia. Semin Perinatol 1999; 23: 24–33
   PubMed Web of Science ®Google Scholar
• Taylor R N. Review: Immunobiology of preeclampsia. Am J Reprod Immunol 1997; 37: 79–86
   PubMed Web of Science ®Google Scholar
• Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today 1999; 20: 114–118
   PubMedGoogle Scholar
• Reinhard G, Noll A, Schlebusch H, Mallmann P, Ruecker A V. Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes. Biochem Biophys Res Commun 1998; 245: 933–938
   PubMed Web of Science ®Google Scholar
• Redman C W, Sacks G P, Sargent I L. Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180: 499–506
   PubMed Web of Science ®Google Scholar
• Conrad K P, Benyo D F. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997; 37: 240–249
   PubMed Web of Science ®Google Scholar
• Hamai Y, Fujii T, Yamashita T, Nishina H, Kozuma S, Mikami Y, Taketani Y. Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 1997; 38: 89–93
   PubMed Web of Science ®Google Scholar
• Gardosi J. Customized growth curves. Clin Obstet Gynecol 1997; 40: 715–722
   PubMed Web of Science ®Google Scholar
• Carr D B, McDonald G B, Brateng D, Desai M, Thach C T, Easterling T R. The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia. Obstet Gynecol 2001; 98: 1109–1116
   PubMed Web of Science ®Google Scholar
• Vince G S, Starkey P M, Austgulen R, Kwaitkowski D, Redman C W. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995; 102: 20–25
   PubMedGoogle Scholar
• Kupferminc M J, Peaceman A M, Aderka D, Wallach D, Socol M L. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 1996; 88: 420–427
   PubMed Web of Science ®Google Scholar
• Visser W, Beckmann I, Knook M, Wallenburg H. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia. Acta Obstet Gynecol Scand 2002; 81: 713–719
   PubMed Web of Science ®Google Scholar
• Williams M A, Mahomed K, Farrand A, Woelk G B, Mudzamiri S, Madzime S, King I B, McDonald G B. Plasma tumor necrosis factor-alpha soluble receptor p55 (sTNFp55) concentrations in eclamptic, preeclamptic and normotensive pregnant Zimbabwean women. J Reprod Immunol 1998; 40: 159–173
   PubMed Web of Science ®Google Scholar
• Sanchez S E, Zhang C, Williams M A, Ware-Jauregui S, Larrabure G, Bazul V, Farrand A. Tumor necrosis factor-alpha soluble receptor p55 (sTNFp55) and risk of preeclampsia in Peruvian women. J Reprod Immunol 2000; 47: 49–63
   PubMed Web of Science ®Google Scholar
• Williams M A, Farrand A, Mittendorf R, Sorensen T K, Zingheim R W, O'Reilly G C, King I B, Zebelman A M, Luthy D A. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol 1999; 149: 323–329
   PubMed Web of Science ®Google Scholar
• Greer I A, Lyall F, Perera T, Boswell F, Macara L M. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction?. Obstet Gynecol 1994; 84: 937–940
   PubMed Web of Science ®Google Scholar
• Heyl W, Handt S, Reister F, Gehlen J, Schroder W, Mittermayer C, Rath W. Elevated soluble adhesion molecules in women with pre-eclampsia. Do cytokines like tumour necrosis factor-alpha and interleukin-1beta cause endothelial activation?. Eur J Obstet Gynecol Reprod Biol 1999; 86: 35–41
   PubMed Web of Science ®Google Scholar
• Djurovic S, Clausen T, Wergeland R, Brosstad F, Bera K, Henrikson T. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. Br J Obstet Gynaecol 2002; 109: 759–764
   Google Scholar
• Meekins J W, McLaughlin P J, West D C, McFadyen I R, Johnson P M. Endothelial cell activation by tumour necrosis factor-alpha (TNF-alpha) and the development of pre-eclampsia. Clin Exp Immunol 1994; 98: 110–114
   PubMed Web of Science ®Google Scholar
• Conrad K P, Miles T M, Benyo D F. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998; 40: 102–111
   PubMed Web of Science ®Google Scholar